Recent Posts

Hong Kong fiddles while the world is moving on

The reduction in Hong Kong’s mandatory hotel quarantine period to three days from seven will come as a welcome relief to many in a pandemic-weary population. Whether it will do much to revive the financial centre’s international competitiveness is far more doubtful. In a world where most of its rivals abandoned Covid curbs months ago, the city still looks like ...

Read More »

The future of travel is less exotic

I am writing this from Amritsar, India, in the state of Punjab. The Sikh Golden Temple here is one of India’s leading attractions, and recently I shared space with thousands of people over the course of four or five hours. In that time, I saw only two people who might qualify as White Westerners. That simple observation — and my ...

Read More »

Pfizer’s GBT deal to aid more sickle-cell patients

  Pfizer continues to spend its Covid windfall wisely. The pharma company said it would spend $5.4 billion to buy Global Blood Therapeutics (GBT), which has one approved drug to treat sickle-cell disease and two more in development. It’s a smart deal for both companies. Pfizer can put needed marketing muscle behind GBT’s products. In return, Pfizer will be able ...

Read More »
Send this to a friend